CongBao Kang

Experimental Drug Development Centre

Papers

1

Total Citations

103

H-Index

1

About

CongBao Kang is a structural biologist and virologist whose research focuses on the molecular mechanisms of viral replication and the development of antiviral therapeutics. His work has significantly advanced the understanding of Zika virus protease as a promising drug target, as demonstrated by his highly cited 2017 study on the subject, which has garnered over 100 citations. This foundational paper elucidated the structural and functional properties of the Zika virus NS2B-NS3 protease, providing critical insights for rational drug design against emerging flaviviruses. Beyond this landmark contribution, Kang’s research spans the structural characterization of viral proteins, including those from dengue and other RNA viruses, employing techniques such as NMR spectroscopy and X-ray crystallography. His work has been instrumental in identifying small-molecule inhibitors and understanding viral-host interactions, earning him recognition as a leading voice in antiviral drug discovery. With a citation record that reflects the high impact of his studies on the global scientific community, Kang continues to drive innovation in combating viral threats, making his research essential reading for students and researchers in structural virology and drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
103
Total Citations
103
Avg Citations/Paper
🏆 Most Cited Paper
Zika Virus Protease: An Antiviral Drug Target
103 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Experimental Drug Development Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago